Literature DB >> 20501937

Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.

Bahram Razani1, Brian Zarnegar, A Jimmy Ytterberg, Travis Shiba, Paul W Dempsey, Carl F Ware, Joseph A Loo, Genhong Cheng.   

Abstract

Canonical and noncanonical nuclear factor kappaB (NF-kappaB) signaling are the two basic pathways responsible for the release of NF-kappaB dimers from their inhibitors. Enhanced NF-kappaB signaling leads to inflammatory and proliferative diseases; thus, inhibitory pathways that limit its activity are critical. Whereas multiple negative feedback mechanisms control canonical NF-kappaB signaling, none has been identified for the noncanonical pathway. Here, we describe a mechanism of negative feedback control of noncanonical NF-kappaB signaling that attenuated the stabilization of NF-kappaB-inducing kinase (NIK), the central regulatory kinase of the noncanonical pathway, induced by B cell-activating factor receptor (BAFF-R) and lymphotoxin beta receptor (LTbetaR). Inhibitor of kappaB (IkappaB) kinase alpha (IKKalpha) was previously thought to lie downstream of NIK in the noncanonical NF-kappaB pathway; we showed that phosphorylation of NIK by IKKalpha destabilized NIK. In the absence of IKKalpha-mediated negative feedback, the abundance of NIK increased after receptor ligation. A form of NIK with mutations in the IKKalpha-targeted serine residues was more stable than wild-type NIK and resulted in increased noncanonical NF-kappaB signaling. Thus, in addition to the regulation of the basal abundance of NIK in unstimulated cells by a complex containing tumor necrosis factor receptor-associated factor (TRAF) and cellular inhibitor of apoptosis (cIAP) proteins, IKKalpha-dependent destabilization of NIK prevents the uncontrolled activity of the noncanonical NF-kappaB pathway after receptor ligation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501937      PMCID: PMC2913610          DOI: 10.1126/scisignal.2000778

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  41 in total

1.  RelB cellular regulation and transcriptional activity are regulated by p100.

Authors:  Nancie J Solan; Hiroko Miyoshi; Eva M Carmona; Gary D Bren; Carlos V Paya
Journal:  J Biol Chem       Date:  2001-10-30       Impact factor: 5.157

2.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Authors:  G S Cheema; V Roschke; D M Hilbert; W Stohl
Journal:  Arthritis Rheum       Date:  2001-06

5.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Authors:  Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.

Authors:  J Zhang; V Roschke; K P Baker; Z Wang; G S Alarcón; B J Fessler; H Bastian; R P Kimberly; T Zhou
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.

Authors:  Arnold I Chin; Paul W Dempsey; Kevin Bruhn; Jeff F Miller; Yang Xu; Genhong Cheng
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

8.  Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.

Authors:  Parameswaran Ramakrishnan; Wangxia Wang; David Wallach
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

9.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

Authors:  Estefania Claudio; Keith Brown; Sun Park; Hongshan Wang; Ulrich Siebenlist
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

10.  Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.

Authors:  A Matsushima; T Kaisho; P D Rennert; H Nakano; K Kurosawa; D Uchida; K Takeda; S Akira; M Matsumoto
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  56 in total

1.  Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.

Authors:  Shao-Cong Sun
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 3.  Return to homeostasis: downregulation of NF-κB responses.

Authors:  Jürgen Ruland
Journal:  Nat Immunol       Date:  2011-06-19       Impact factor: 25.606

Review 4.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

Review 5.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

6.  Nano NiO induced liver toxicity via activating the NF-κB signaling pathway in rats.

Authors:  Fangfang Liu; Xuhong Chang; Minmin Tian; An Zhu; Lingyue Zou; Aijie Han; Li Su; Sheng Li; Yingbiao Sun
Journal:  Toxicol Res (Camb)       Date:  2017-02-08       Impact factor: 3.524

Review 7.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

8.  RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization.

Authors:  Giel Tanghe; Corinne Urwyler-Rösselet; Philippe De Groote; Emmanuel Dejardin; Pieter-Jan De Bock; Kris Gevaert; Peter Vandenabeele; Wim Declercq
Journal:  Cell Mol Life Sci       Date:  2018-02-12       Impact factor: 9.261

9.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

10.  Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival.

Authors:  Stella M Ranuncolo; Stefania Pittaluga; Moses O Evbuomwan; Elaine S Jaffe; Brian A Lewis
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.